Effects of Combined Grape Seed Extract and L-citrulline Supplementation on Hemodynamic Responses in Young Males

Sponsor
California Baptist University (Other)
Overall Status
Completed
CT.gov ID
NCT05116150
Collaborator
(none)
11
1
2
6
1.8

Study Details

Study Description

Brief Summary

This study was to examine the additive benefits with combined grape seed extract (GSE) and L-citrulline supplementation on hemodynamic responses to dynamic exercise, 11 young, healthy males were recruited for this study.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Grape seed extract
  • Dietary Supplement: Placebo
N/A

Detailed Description

The investigators aimed the additive effects of combined grape seed extract (GSE) and L-citrulline supplementation on hemodynamic responses to dynamic exercise, 11 young, healthy males were recruited for this study. Effects of 7 days of combined GSE with L-citrulline supplementation on systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial blood pressure (MAP), cardiac output (CO), total vascular conductance (TVC), and oxygen consumption (O2) were examined at rest and during cycling exercise.

Study Design

Study Type:
Interventional
Actual Enrollment :
11 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Prevention
Official Title:
Effects of Combined Grape Seed Extract and L-citrulline Supplementation on Hemodynamic Responses in Young Males
Actual Study Start Date :
Jun 1, 2019
Actual Primary Completion Date :
Dec 1, 2019
Actual Study Completion Date :
Dec 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Randomized double blind grape seed extract design

Grape see extract

Dietary Supplement: Grape seed extract
Effects of 7 days of combined GSE with L-citrulline supplementation on hemodynamic responses at rest and during cycling exercise.

Dietary Supplement: Placebo
Effects of 7 days of placebo supplementation on hemodynamic responses at rest and during cycling exercise.

Placebo Comparator: Randomized double blind placebo design

Placebo

Dietary Supplement: Grape seed extract
Effects of 7 days of combined GSE with L-citrulline supplementation on hemodynamic responses at rest and during cycling exercise.

Dietary Supplement: Placebo
Effects of 7 days of placebo supplementation on hemodynamic responses at rest and during cycling exercise.

Outcome Measures

Primary Outcome Measures

  1. Systolic blood pressure (mmHg) [7 days]

    by sphygmomanometer

  2. Diastolic blood pressure (mmHg) [7 days]

    by sphygmomanometer

  3. Mean arterial pressure (mmHg) [7 days]

    calculated (MAP = (SBP-DBP)/3 + DBP

  4. Heart rate (bpm) [7 days]

    measured using Physio Flow (non-invasive device)

  5. Stroke volume (ml) [7 days]

    measured using Physio Flow (non-invasive device)

  6. Cardiac output (l/min) [7 days]

    calculated: HR (bpm) x SV (ml)

  7. Total vascular conductance (ml/min/mmHg) [7 days]

    calculated: CO (ml/min) / MAP (mmHg)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 30 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • healthy males
Exclusion Criteria:
  • cardiovascular and/or pulmonary disease, musculoskeletal disorders, or medications that prevent the safe completion of the exercise protocol

Contacts and Locations

Locations

Site City State Country Postal Code
1 California Baptist University Riverside California United States 92504

Sponsors and Collaborators

  • California Baptist University

Investigators

  • Principal Investigator: Jong-Kyung Kim, Ph.D, California Baptist University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
California Baptist University
ClinicalTrials.gov Identifier:
NCT05116150
Other Study ID Numbers:
  • 112-1819 EXP
First Posted:
Nov 10, 2021
Last Update Posted:
Nov 10, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 10, 2021